Showing results (1-10 of 197) with videos related to
Sort By:
Pageof 20
Blood|July 28, 2018
Targeted therapy for fusion-driven high-risk acute leukemiaYana Pikman, Kimberly StegmaierCurrent Opinion in Pediatrics|January 4, 2021
Targeting the Ras pathway in pediatric hematologic malignanciesYana Pikman, Elliot StieglitzActa Haematologica|January 16, 2024
Pathophysiology of Acute Myeloid LeukemiaFranziska Wachter, Yana PikmanBlood Advances|August 30, 2023
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemiaAmy N Sexauer, Gabriela Alexe, Karin Gustafsson, et al.Current Opinion in Oncology|October 2, 2007
Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disordersYana Pikman, Ross L LevineBest Practice & Research. Clinical Haematology|March 7, 2006
Genomic approaches in acute leukemiaKimberly StegmaierOphthalmic Genetics|June 7, 2006
Peters anomaly in association with multiple midline anomalies and a familial chromosome 4 inversionEdward Neilan, Yana Pikman, Virginia E KimonisPlos One|January 31, 2008
The CDK-activating kinase (CAK) Csk1 is required for normal levels of homologous recombination and resistance to DNA damage in fission yeastHilary B Gerber, Yana Pikman, Robert P FisherCritical Reviews in Oncogenesis|December 14, 2011
Targeting NOTCH1 in hematopoietic malignancyGiovanni Roti, Kimberly StegmaierBritish Journal of Cancer|February 5, 2020
Targeting DUBs to degrade oncogenic proteinsAnjali Cremer, Kimberly StegmaierPageof 20